Please log in to determine if you are eligible to purchase PT Programs.
HPV (HIGH RISK) FOR CYTOPATHOLOGY - CHPV
CHPV
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Analyte/Procedure
Challenges per Shipment
Number of Shipments
HPV
5
Three shipments per year
High‑risk HPV genotyping (optional)
5
Additional Information
The specimens in this program are not intended to be specific to a transport medium. Laboratories should perform testing using the transport media used in their facility.
For laboratories that perform high-risk HPV (HrHPV) genotyping in-house, this program provides opportunities to report specific HPV genotypes, which are educational.
The CAP does not report genotyping responses to the CMS.